The Role of Innovation Policies in the Brazilian Health Biotechnology Regime

REFERENCES

• Agência Brasileira de Desenvolvimento Industrial . ( 2009 ). Ambiente institucional da biotecnologia no Brasil . Brasília , DF : ABDI-MDIC .
   Google Scholar
• Agência Brasileira de Desenvolvimento Industrial; Centro de Gestão e Estudos Estratégicos . ( 2009 ). Biotecnologia iniciativa nacional de inovação estudo prospectivo visão de futuro e agenda INI -Biotecnologia: 2008–2025: relatório final . Brasília , DF : Authors .
   Google Scholar
• Anciães , W. , and Cassiolato , J. E. ( 1985 ). Biotecnologia seus impactos no setor industrial . Brasília , DF : CNPq .
   Google Scholar
• Arocena , R. , and Sutz , J. ( 2000 ). Looking at National System of Innovation from the South . Industry and Innovation , 7 ( 1 ), 55 – 75 .
   Google Scholar
• Arrow , K. ( 1962 ). Economic welfare and the allocation of resources for invention . In Universities-National Bureau, The rate and direction of inventive activity: Economic and social factors (pp. 609 – 626 ). Cambridge , MA : NBER .
   Google Scholar
• Arundel , A. , and Mintzes , B. ( 2004 ). The benefits of biopharmaceuticals. [Innogen Working Paper n° 14] . Economic & Social Research Council . Swindon .
   Google Scholar
• Associação Brasileira de Biotecnologia; Centro Brasileiro de Análise e Planejamento . ( 2011 ). Brazil Biotech Map 2011 . São Paulo : Author .
   Google Scholar
• Avila , J. ( 2004 ). O desenvolvimento do setor farmacêutico: o caminho de uma estratégia centrada na inovação . Revista Brasileira de Inovação , 3 ( 2 ), 283 – 307 .
   Google Scholar
• Bianchi , C. ( 2012 ). Grupos de pesquisa em biotecnologia moderna no Brasil: Uma revisão sobre os fundamentos da política de CTI . Revista Iberoamericana de Ciencia, Tecnología y Sociedad , 7 ( 21 ), 23 – 43 .
   Google Scholar
• Biominas Brasil . ( 2001 ). Parque nacional de empresas de biotecnologia . Belo Horizonte : Author .
   Google Scholar
• Biominas Brasil. ( 2007 ). Estudo de empresas de biotecnologia do Brasil . Belo Horizonte : Author .
   Google Scholar
• Biominas Brasil . ( 2009 ). Diretório de empresas de biociências 2009 . Belo Horizonte : Author .
   Google Scholar
• Biotecsur. ( 2010 ). Catálogo de empresas y centros de investigación. Retrieved from http://www.biotecsur.org/
   Google Scholar
• Cardoso , T. , Albuquerque Navarro , M. , Soares , B. , Lima e Silva , L. , Rocha , S. , and Oda , L. ( 2005 ). Memories of biosafety in Brazil: Lessons to be learned . Applied Biosafety , 10 ( 3 ), 160 – 168 .
   Google Scholar
• Casper , S. ( 2007 ). Creating silicon valley in Europe: public policy towards new technology industries . New York : Oxford University Press .
   Google Scholar
• Cornes , R. , and Sandler , T. (1996). The theory of externalities, public goods and club goods . Cambridge , MA : Cambridge University Press.
   Google Scholar
• Diretrizes de Política Industrial, Tecnológica e de Comércio Exterior . ( 2003 ). Elaborado pelo Ministério de Ciência e Tecnologia . Brasília , DF : MDIC .
   Google Scholar
• Edquist , C. ( 1999 , June ). Innovation policy: a systemic approach. Proceedings of the DRUID Summer Conference on National Innovation Systems, Industrial Dynamics and Innovation Policy, Aalborg, 7.
   Google Scholar
• Encontro Nacional de Inovação Tecnológica em Biotecnologia. ( 2009 ). Cadastro de empresas participantes no Encontro Enconit-Biotec 2009 . Rio de Janeiro : Author .
   Google Scholar
• Ferrer , M. , Thorsteinsdóttir , H. , Quach , U. , Singer , P. , and Daar , A. ( 2004 ). The scientific muscle of Brazil's health biotechnology . Nature Biotechnology , 22 ( 12 ), DC8 – DC10 .
   PubMedGoogle Scholar
• Fonseca , M. G. D. ( 2009 ). Documento setorial: biotecnologia . In: Albuquerque , E. (Coord.) , Projeto perspectivas do investimento no Brasil bloco: economia do conhecimento sistema produtivo: baseados em ciência . Rio de Janeiro : IE/UFRJ; IE/Unicamp .
   Google Scholar
• Furtado , J. , and Urias , E. ( 2010 ). A evolução da indústria farmacêutica no Brasil: elementos para uma caracterização dos movimentos recentes, com ênfase nas políticas de inovação . São Paulo : Proyecto Políticas Regionales de Innovación en el MERCOSUR: obstáculos y oportunidades .
   Google Scholar
• Gadelha , C. ( 1990 ). Biotecnologia em saúde: um estudo da mudança tecnológica na indústria farmacêutica e das perspectivas de seu desenvolvimento no Brasil (Dissertação de mestrado). Instituto de Economia, Universidade Estadual de Campinas, Campinas, São Paulo, Brasil.
   Google Scholar
• Gadelha , C. A. G. , Maldonado , J. , Vargas , M. , and Barbosa , P. R. ( 2009 ). Complexo econômico-industrial da saúde . In: Gadelha , C. A. G. (Coord.) , Projeto perspectivas do investimento no Brasil: bloco economia do conhecimento . Rio de Janeiro : IE/UFRJ; IE/Unicamp .
   Google Scholar
• Gans , J. S. , Hsu , D. H. , and Stern , S. ( 2002 ). When does start-up innovation spur the gale of creative destruction? RAND Journal of Economics , 33 ( 4 ), 571 – 586 .
   Web of Science ®Google Scholar
• Hopkins , M. , Martin , P. , Nightingale , P. , Kraft , A. , and Mahdi , S. ( 2007 ). The myth of the biotech revolution: An assessment of technological, clinical and organisational change . Research Policy , 36 , 566 – 589 .
   Web of Science ®Google Scholar
• Malerba , F. , and Orsenigo , L. ( 2002 ). Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: Towards a history friendly model . Industrial and Corporate Change , 11 ( 4 ), 667 – 703 .
   Web of Science ®Google Scholar
• McKelvey , M. , and Orsenigo , L. ( 2001 ). Pharmaceuticals as a sectoral innovation system [Paper prepared for the ESSY Project]. Retrieved from http://www.druid.dk/uploads/tx_picturedb/dw2002-447.pdf
   Google Scholar
• McMillan , G. , Narin , F. , and Deeds , D. ( 2000 ). An analysis of the critical role of public science in innovation: The case of biotechnology . Research Policy , 29 , 1 – 8 .
   Web of Science ®Google Scholar
• Mendonça , M. , and Freitas , R. ( 2008 ). Biotecnologia: perfil dos grupos de pesquisa no Brasil. Anais do Congresso da Sociedade Brasileira de Economia, Administração e Sociologia Rural, Rio Branco, Acre, 46.
   Google Scholar
• Metcalfe , S. ( 2003 , November ). . Systems failure and the case for innovation policy . Proceedings of the Canada-UK Colloquia : Science and Public Policy, South Gloucester .
   Google Scholar
• Mytelka , L. , and Smith , K. (2002). Policy learning and innovation theory: An interactive and co-evolving process. Research Policy , 31, 1467–1479.
   Web of Science ®Google Scholar
• Nelson , R. ( 1959 ). The simple economics of basic scientific research . Journal of Political Economy , 67 , 297 – 306 .
   Web of Science ®Google Scholar
• Niosi , J. ( 2003 ). Alliances are not enough explaining rapid growth in biotechnology firms . Research Policy , 32 , 737 – 750 .
   Web of Science ®Google Scholar
• Niosi , J. , and Banik , M. ( 2005 ). The evolution and performance of biotechnology regional systems of innovation . Cambridge Journal of Economics , 29 , 343 – 357 .
   Web of Science ®Google Scholar
• Oakley , R. ( 1993 ). Predatory networking: The role of small firms in the development of the British biotechnology industry . International Small Business Journal , 11 ( 4 ), 9 – 22 .
   Google Scholar
• Organization for Economic Co-Operation, and Development . ( 2005 ). A framework for biotechnology statistics . Paris : Author .
   Google Scholar
• Organization for Economic Co-Operation, and Development . ( 2006 ). Innovation in pharmaceutical biotechnology: Comparing national innovation systems at the sectoral level . Paris : Author .
   Google Scholar
• Orsenigo , L. ( 1989 ). The emergence of biotechnology . London : Palgrave Macmillan .
   Google Scholar
• Orsenigo , L. , Dosi , G. , and Mazzucato , M. ( 2006 ). The dynamics of knowledge accumulation, regulation, and appropriability in the pharmabiotech sector: Policy issues . In Mazzucato , M. , & Dosi , G. (Eds.), Knowledge accumulation and industry evolution . Cambridge , England : Cambridge University Press .
   Google Scholar
• Orsenigo , L. , Pammolli , F. , and Riccaboni , M. ( 2001 ). Technological change and network dynamics. Lessons from the pharmaceutical industry . Research Policy , 30 , 485 – 508 .
   Web of Science ®Google Scholar
• Patzelt , H. , and Brenner , T. (Ed.). ( 2008 ). Handbook of bioentrepreneurship . New York : Springer Science+Business Media .
   Google Scholar
• Pisano , G. ( 2006 ). Science business: the promise, the reality and the future of biotech . Boston : Harvard University Press .
   Google Scholar
• Plano de ação 2007–2010 da ciência, tecnologia e inovação para o desenvolvimento . ( 2007 ). Elaborado pelo Ministério de Ciência e Tecnologia . Brasília , DF : MCT .
   Google Scholar
• Política de desenvolvimento da biotecnologia . ( 2007 ). Elaborado pela Agência Brasileira de Desenvolvimento Industrial . Brasília , DF : ABDI .
   Google Scholar
• Política de desenvolvimento produtivo . ( 2008 ). Elaborado pelo Ministério do Desenvolvimento, Indústria e Comércio Exterior . Brasília , DF : MDIC .
   Google Scholar
• Powell , W. , Koput , K. , and Smith-Doerr , L. ( 1996 , March ). Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology . Administrative Science Quarterly , 41 ( 1 ), 116 – 145 .
   Web of Science ®Google Scholar
• Rezaie , R. , Frew , S. , Sammut , S. , Maliakkal , M. , Daar , A. , and Singer , P. ( 2008 , June ). Brazilian health biotech: Fostering crosstalk between public and private sectors . Nature Biotechnology , 26 ( 6 ) 627 – 644 .
   PubMed Web of Science ®Google Scholar
• Ryan , M. ( 2010 ). Patent incentives, technology markets, and public-private bio-medical innovation networks in Brazil . World Development , 38 ( 8 ), 1082 – 1093 .
   Web of Science ®Google Scholar
• Stinson , J ( 1999 ). The development of new medicines: an overview . In: Walsh , G. & Murphy , B. Biopharmaceuticals, an industrial perspective . Dordrecht : Kluwer Academic Publishers .
   Google Scholar
• Stuart , T. , Zeki O., Salih. D., and Waverly , W. ( 2007 ). Vertical alliance networks: the case of university–biotechnology–pharmaceutical alliance chains . Research Policy , 36 , 477 – 498 .
   Web of Science ®Google Scholar
• Vargas , M. A. (2009). Documento setorial: farmacêutica. In: Gadeglia , C. G. (Coord.), Projeto perspectivas do investimento no Brasil: sistema produtivo: complexo industrial da saúde . Rio de Janeiro : IE/UFRJ; IE/Unicamp.
   Google Scholar
• Weltman , W. ( 2002 ). A produção científica publicada pelo Instituto Oswaldo Cruz no período 1900–17: um estudo exploratório . História, Ciências, Saúde , 9 ( 1 ), 159 – 186 .
   PubMedGoogle Scholar